News & Updates

In the phase II NEOBLADE* trial, the addition of the multikinase** inhibitor nintedanib to neoadjuvant chemotherapy (CT) consisting of gemcitabine and cisplatin failed to improve pathological complete response (pCR) and progression-free survival (PFS) in individuals with locally advanced muscle-invasive bladder cancer (MIBC).

Men with inflammatory bowel disease (IBD) have a slightly reduced fertility, and this is observed in both ulcerative colitis and Crohn’s disease, as reported in a study.

The use of holmium laser enucleation of the prostate (HoLEP) and robotic-assisted simple prostatectomy (RASP) deliver comparable and good postoperative outcomes in patients with large benign prostatic hyperplasia (BPH), a new study has found.

Frailty is associated with a higher relative risk of 30-day complications, 1-year mortality, and repeat procedures for persistent incontinence or obstructed voiding at 1 year after sling surgery in older adults, suggests a recent study.

Men receiving testosterone therapy (TT) who develop polycythemia are at greater risk for major adverse cardiovascular events (MACE) and venous thromboembolism (VTE) in the first year of therapy, according to a recent study.

Prostate cancer (PCa) patients with higher lymph node (LN) risk scores and Gleason grade who are treated with whole pelvis radiotherapy (WPRT) have better overall survival (OS), reports a study.

Chemotherapy with 5-fluorouracil (5FU) and mitomycin C (MMC), when combined with radiotherapy, leads to better locoregional control over a 10-year window in patients with muscle-invasive bladder cancer (MIBC), a recent study has found.